CLINICAL_TRIALS
trial_result
· 2009-09-23
Clinical Trial Update: Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients [Phase 2]
Summary
Phase 2 study evaluating antiviral activity and safety of three different doses of mifepristone in hepatitis C patients; results were posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VGX Pharmaceuticals, LLC | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2009-09-23